Rheumatoid Arthritis: New Advances in Personalized Therapies
A special issue of Journal of Personalized Medicine (ISSN 2075-4426). This special issue belongs to the section "Personalized Therapy and Drug Delivery".
Deadline for manuscript submissions: 30 July 2025 | Viewed by 26
Special Issue Editor
Interests: systemic sclerosis; interstitial lung disease; rheumatoid arthritis; inflammatory rheumatic diseases
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Presently, healthcare is moving towards a patient-centered care approach. Therefore, the therapy management of rheumatoid arthritis is changing as well. In recent decades, new drugs have emerged, creating more choices for people. However, until now, there has not been a therapy that works for all patients. Patients may find themselves cycling through medications, hence risking prolonged symptoms and disease progression until a suitable treatment is found. Personalized medicine is centered around developing and tailoring medication decisions to patients based on their unique characteristics or biomarkers. Existing evidence suggests that the implementation of personalized medicine in daily practice for rheumatoid arthritis should be our priority. Therefore, new data will bring advances in the personalized treatment of patients with rheumatoid arthritis.
Dr. Serena Guiducci
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- rheumatoid arthritis
- therapy management
- disease progression
- personalized medicine
- biomarkers
- personalized therapy
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
